Isolation and structural characterisation of the degradation products of tazemetostat hydrobromide, an FDA-approved EZH2 inhibitor: Evidence for two distinct N-oxidation pathways

Journal of Molecular Structure 2026

View at publisher

Authors: Sasikala Talari, Pooja Tanaji Nelwade, Rajesh Sonti

DOI: 10.1016/j.molstruc.2026.146071

Cited by: 2

References: 28

Fields of Study & Subjects

Biochemical and Molecular Research Cancer Hypoxia and Metabolism Histone Deacetylase Inhibitors Research

References 28